Amedeo's Top 20

Amedeo Smart

Independent Medical Education

21 November 2022

Multidisciplinary Journal Club

  1. Herrington WG, Staplin N, Wanner C, Green JB, et al.
    Empagliflozin in Patients with Chronic Kidney Disease.
    N Engl J Med 2022.

  1. Hawkey C, Avery A, Coupland CAC, Crooks C, et al.
    Helicobacter pylori eradication for primary prevention of peptic ulcer bleeding in older patients prescribed aspirin in primary care (HEAT): a randomised, double-blind, placebo-controlled trial.
    Lancet 2022;400:1597-1606.

  2. Yuen MF, Lim SG, Plesniak R, Tsuji K, et al.
    Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
    N Engl J Med 2022.

  3. Bhandari S, Mehta S, Khwaja A, Cleland JGF, et al.
    Renin-Angiotensin System Inhibition in Advanced Chronic Kidney Disease.
    N Engl J Med 2022.

  4. Williams CM, Muhammad AK, Sambou B, Bojang A, et al.
    Exhaled Mycobacterium tuberculosis Predicts Incident Infection in Household Contacts.
    Clin Infect Dis 2022.

  1. Eguchi MM, Elder DE, Barnhill RL, Piepkorn MW, et al.
    Prognostic modeling of cutaneous melanoma stage I patients using cancer registry data identifies subsets with very-low melanoma mortality.
    Cancer 2022.

  2. Yang P, Song L, Zhang Y, Zhang X, et al.
    Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.
    Lancet 2022;400:1585-1596.

  3. Mann JFE, Joseph P, Gao P, Pais P, et al.
    Effects of aspirin on cardiovascular outcomes in patients with chronic kidney disease.
    Kidney Int 2022.

  4. Houillier C, Dureau S, Taillandier L, Houot R, et al.
    Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study.
    J Clin Oncol 2022.

  5. Park JS, Cho YJ, Yun JY, Lee HJ, et al.
    Leukotriene receptor antagonists and risk of neuropsychiatric events in children, adolescents and young adults: a self-controlled case series.
    Eur Respir J 2022;60.

  1. Freeman MW, Halvorsen YD, Marshall W, Pater M, et al.
    Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.
    N Engl J Med 2022.

  2. Wei T, Cho L.
    Recent lipoprotein(a) trials.
    Curr Opin Lipidol 2022;33:301-308.

  3. Zoller H, Wolf M, Blumenstein I, Primas C, et al.
    Hypophosphataemia following ferric derisomaltose and ferric carboxymaltose in patients with iron deficiency anaemia due to inflammatory bowel disease (PHOSPHARE-IBD): a randomised clinical trial.
    Gut 2022.

  4. Adolph TE, Zhang J.
    Diet fuelling inflammatory bowel diseases: preclinical and clinical concepts.
    Gut 2022;71:2574-2586.

  5. Carey RM, Moran AE, Whelton PK.
    Treatment of Hypertension: A Review.
    JAMA 2022;328:1849-1861.

  1. Hochman JS, Anthopolos R, Reynolds HR, Bangalore S, et al.
    Survival After Invasive or Conservative Management of Stable Coronary Disease.
    Circulation 2022.

  2. Kang J, Park KW, Lee H, Hwang D, et al.
    Aspirin vs. Clopidogrel for Chronic Maintenance Monotherapy after Percutaneous Coronary Intervention: the HOST-EXAM Extended Study.
    Circulation 2022.

  3. Agarwal S, Shiau S, Kamanda-Kosseh M, Bucovsky M, et al.
    Teriparatide Followed by Denosumab in Premenopausal Idiopathic Osteoporosis: Bone Microstructure and Strength by HR-pQCT.
    J Bone Miner Res 2022.

  4. .
    Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials.
    Lancet 2022.

  5. Pereira TV, Juni P, Saadat P, Xing D, et al.
    Viscosupplementation for knee osteoarthritis: systematic review and meta-analysis.
    BMJ 2022;378:e069722.


more..

Privacy Policy